X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.catalent.com/catalent-news/protokinetix-announces-selection-of-aagp-candidate-formulations-for-treatment-of-dry-eye-disease/
https://www.catalent.com/catalent-news/protokinetix-announces-selection-of-aagp-candidate-formulations-for-treatment-of-dry-eye-disease/
https://www.businesswire.com/news/home/20210512005144/en/ProtoKinetix-and-IQVIA-Partner-to-Support-Development-of-AAGP%C2%AE-Product-in-the-Treatment-of-Ocular-Conditions
https://www.businesswire.com/news/home/20210422005429/en/ProtoKinetix-Announces-the-Resumption-of-Phase-1b-Clinical-Trials-for-the-use-of-AAGP%C2%AE-Treated-Islet-Cells-in-the-Treatment-of-Type-1-Diabetes
https://www.businesswire.com/news/home/20201124005302/en/Research-Paper-Showing-ProtoKinetix-AAGP%C2%AE-Enhanced-Stem-Cell-Derived-Retina-Precursor-Cells-Restoration-of-Vision
https://www.biospace.com/article/releases/protokinetix-aagp-restores-vision-in-blind-test-subjects/#:~:text=MARIETTA%2C%20Ohio%2D%2D(BUSINESS%20WIRE,retinal%20cells%20was%20conclusively%20achieved.
https://www.globenewswire.com/news-release/2020/04/06/2012149/0/en/American-BriVision-Conducts-Site-Monitoring-Visit-for-Phase-II-Part-I-Clinical-Trial-for-ABV-1505-in-Adult-Attention-Deficit-Hyperactivity-Disorder-ADHD.html
Market Place
Share 
